BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 7902432)

  • 1. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.
    Gasior M; Paronis CA; Bergman J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):249-59. PubMed ID: 14563783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.
    Spealman RD; Bergman J; Madras BK; Melia KF
    J Pharmacol Exp Ther; 1991 Sep; 258(3):945-53. PubMed ID: 1679852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
    Bergman J; Madras BK; Spealman RD
    J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
    Witkin JM; Nichols DE; Terry P; Katz JL
    J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; PrzegaliƄski E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.
    Haile CN; Carey G; Varty GB; Coffin VL
    Eur J Pharmacol; 2000 Jan; 388(2):125-31. PubMed ID: 10666503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.
    Terry P; Witkin JM; Katz JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1041-8. PubMed ID: 7932151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Rosenzweig-Lipson S; Spealman RD
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.